Sonus looks for EchoGen distributor as Abbott ends link
This article was originally published in Clinica
Abbott has terminated the US marketing agreement with Sonus Pharmaceuticals for the development stage company's EchoGen ultrasound contrast imaging agent. This leaves Sonus looking for a salesforce for the product. It was announced in February they were renegotiating their agreement.